Ventyx Biosciences Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scroll to see more
Ventyx Biosciences, Inc. income statement - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Revenue & Gross Profit
Revenue0.000.000.000.000.00
Cost of Revenue0.000.000.000.000.00
Gross Profit0.000.000.000.000.00
Operating Expenses
Research & Development117.00175.7787.7458.486.37
Selling, General & Administrative31.4532.2325.408.670.68
Operating Expenses148.45207.99113.14-67.157.05
Operating Income-148.45-207.99-113.14-67.15-7.05
Other Income/Expense
Interest Income13.4215.074.670.080.00
Interest Expense0.000.000.000.10-0.36
Other Income/Expense-0.09-0.040.040.05-20.77
Income
Income Before Tax-135.12-192.96-108.43-83.75-28.17
Income Tax Expense0.000.000.000.000.00
Net Income-135.12-192.96-108.43-83.75-28.17
Net Income - Continuous Operations-135.12-192.96-108.43-83.750.00
Net Income - Discontinued Operations0.000.000.000.000.00
EBITDA-147.10-207.05-113.01-83.620.00
EBIT-148.45-207.99-113.14-83.65-7.05
Depreciation & Amortization1.350.940.12-0.030.00
Earnings Per Share
Basic EPS-2.00-3.00-2.00-7.00-14.00
Diluted EPS-2.00-3.00-2.00-7.00-14.00
Basic Shares Outstanding68.4858.5452.4712.831.99
Diluted Shares Outstanding68.4858.5452.4712.591.99